Liminatus Pharma Ord Shs Class A
LIMN0.773USD
+0.004+0.55%
Close 01/23, 16:00（ET）Quotes delayed by 15 min
20.92MMarket Cap
LossP/E TTM
More Details of Company
Liminatus Pharma Ord Shs Class A Info
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of Liminatus Pharma Ord Shs Class A
Name
Name/Position
Position
Shareholding
Change
Mr. Rohit Nanani
Mr. Rohit Nanani
Director
Director
--
--
Mr. Nicholas Fernandez
Mr. Nicholas Fernandez
Independent Director
Independent Director
--
--
Mr. Chris Kim
Mr. Chris Kim
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Eun Sook Lee, M.D., Ph.D.
Dr. Eun Sook Lee, M.D., Ph.D.
Independent Director
Independent Director
--
--
Ms. Ji Yeon Baek
Ms. Ji Yeon Baek
Independent Director
Independent Director
--
--
Mr. Scott Dam
Mr. Scott Dam
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Sang-jin Daniel Lee
Mr. Sang-jin Daniel Lee
Head - Research & Development
Head - Research & Development
--
--
Dr. Byong C. Yoo, Ph.D.
Dr. Byong C. Yoo, Ph.D.
Chief Science Officer
Chief Science Officer
--
--
Mr. Beom K. Choi
Mr. Beom K. Choi
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Philip Lemons
Mr. Philip Lemons
Director
Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Rohit Nanani
Mr. Rohit Nanani
Director
Director
--
--
Mr. Nicholas Fernandez
Mr. Nicholas Fernandez
Independent Director
Independent Director
--
--
Mr. Chris Kim
Mr. Chris Kim
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Eun Sook Lee, M.D., Ph.D.
Dr. Eun Sook Lee, M.D., Ph.D.
Independent Director
Independent Director
--
--
Ms. Ji Yeon Baek
Ms. Ji Yeon Baek
Independent Director
Independent Director
--
--
Mr. Scott Dam
Mr. Scott Dam
Chief Financial Officer
Chief Financial Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Wed, Dec 10
Updated: Wed, Dec 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Iris Acquisition Holdings LLC
25.49%
Valetudo Therapeutics LLC
22.80%
Feelux Co Ltd
14.78%
Ewon Comfortech Co Ltd
5.54%
Red Peony Association 1st
5.43%
Other
25.96%
Shareholders
Shareholders
Proportion
Iris Acquisition Holdings LLC
25.49%
Valetudo Therapeutics LLC
22.80%
Feelux Co Ltd
14.78%
Ewon Comfortech Co Ltd
5.54%
Red Peony Association 1st
5.43%
Other
25.96%
Shareholder Types
Shareholders
Proportion
Corporation
79.47%
Investment Advisor
0.47%
Investment Advisor/Hedge Fund
0.34%
Research Firm
0.15%
Other
19.56%
Institutional Shareholding
Updated: Wed, Jan 21
Updated: Wed, Jan 21
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
13
261.92K
0.76%
--
2025Q4
19
261.92K
0.97%
-161.71K
2025Q3
21
261.92K
0.97%
-218.50K
2025Q2
19
204.70K
0.79%
-924.41K
2025Q1
11
--
0.00%
-1.16M
2024Q4
23
--
0.00%
-6.45M
2024Q3
70
16.83K
0.23%
-24.70M
2024Q2
75
146.55K
2.04%
-25.63M
2024Q1
79
231.31K
3.22%
-26.92M
2023Q4
79
236.25K
3.24%
-27.04M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Iris Acquisition Holdings LLC
6.90M
25.49%
--
--
Jul 23, 2025
Valetudo Therapeutics LLC
6.17M
22.8%
--
--
Jul 23, 2025
Feelux Co Ltd
4.00M
14.78%
--
--
Jul 23, 2025
Ewon Comfortech Co Ltd
1.50M
5.54%
--
--
Jul 23, 2025
Red Peony Association 1st
1.47M
5.43%
--
--
Jul 23, 2025
Nongae Apple Association 1st
1.47M
5.43%
--
--
Jul 23, 2025
The Vanguard Group, Inc.
73.42K
0.27%
--
--
Sep 30, 2025
Geode Capital Management, L.L.C.
63.73K
0.24%
-107.00
-0.17%
Sep 30, 2025
UBS Financial Services, Inc.
40.53K
0.15%
+9.04K
+28.71%
Sep 30, 2025
Jane Street Capital, L.L.C.
39.63K
0.15%
+39.63K
--
Sep 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
